An internal standard for the quantification of olmesartan
Related Products
Unlabeled Version(s)
23412Olmesartan
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Olmesartan-d6

Item No. 36324

Technical Information
Formal Name
4-[1-hydroxy-1-(methyl-d3)ethyl-2,2,2-d3]-2-propyl-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid
CAS Number
1185144-74-4
Molecular Formula
C24H20D6N6O3
Formula Weight
Purity
≥99% deuterated forms (d1-d6)
Formulation
A solid
SMILES
OC(C([2H])([2H])[2H])(C([2H])([2H])[2H])C1=C(C(O)=O)N(CC(C=C2)=CC=C2C3=C(C4=NN=NN4)C=CC=C3)C(CCC)=N1
InChi Code
InChI=1S/C24H26N6O3/c1-4-7-19-25-21(24(2,3)33)20(23(31)32)30(19)14-15-10-12-16(13-11-15)17-8-5-6-9-18(17)22-26-28-29-27-22/h5-6,8-13,33H,4,7,14H2,1-3H3,(H,31,32)(H,26,27,28,29)/i2D3,3D3
InChi Key
VTRAEEWXHOVJFV-XERRXZQWSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Cayman Chemical
    Explore Obesity & Metabolic Disease Resources

    Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.

    OBESITY RESEARCH SOLUTIONS
    Product Description

    Olmesartan-d6 is intended for use as an internal standard for the quantification of olmesartan (Item No. 23412) by GC- or LC-MS. Olmesartan is a non-peptide angiotensin II receptor 1 (AT1) antagonist (IC50 = 0.0077 µM for the bovine adrenal cortex receptor) and an active metabolite of olmesartan medoxomil (Item No. 11614).1 It is formed from olmesartan medoxomil by paraoxonase 1 (PON1) in human plasma.2 Olmesartan is selective for AT1 over AT2 (IC50 = >100 µM for the bovine cerebellar receptor). It reduces contraction of isolated guinea pig aorta induced by angiotensin II (Item No. 17150; pD2 = 9.9) but not phenylephrine (Item Nos. 17205 | 18619) or potassium chloride. Olmesartan (0.01 and 0.03 mg/kg, i.v.) reduces the angiotensin II-induced pressor response in conscious normotensive rats.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Mizuno, M., Sada, T., Ikeda, M., et alPharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist. Eur. J. Pharmacol. 285(2), 181-188 (1995).

    2. Ishizuka, T., Fujimori, I., Nishida, A., et alParaoxonase 1 as a major bioactivating hydrolase for olmesartan medoxomil in human blood circulation: Molecular identification and contribution to plasma metabolism. Drug Metab. Dispos. 40(2), 374-380 (2012).